End-of-day quote
Korea S.E.
23:00:00 13/05/2024 BST
5-day change
1st Jan Change
6,230
KRW
+1.80%
-1.11%
+17.11%
DHP Korea Co., Ltd.'s Equity Buyback announced on March 23, 2020, has expired with 283,523 shares, representing 1.74% for KRW 2,015.98 million.
The company expired its plan on June 23, 2020.
OPTUS Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
15/05/23
CI
Tranche Update on OPTUS Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 7, 2022.
19/10/22
CI
OPTUS Pharmaceutical Co., Ltd.'s Equity Buyback announced on September 7, 2022 has closed with 463,678 shares, representing 2.97% for KRW 2,944.46 million.
17/10/22
CI
OPTUS Pharmaceutical Co., Ltd. announces an Equity Buyback for 463,678 shares.
07/09/22
CI
OPTUS Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
06/09/22
CI
Tranche Update on DHP Korea Co., Ltd.'s Equity Buyback Plan announced on January 21, 2022.
23/03/22
CI
DHP Korea Co., Ltd.'s Equity Buyback announced on January 21, 2022, has expired with 411,635 shares, representing 2.57% for KRW 3,001.58 million.
22/03/22
CI
DHP Korea Co., Ltd. announces an Equity Buyback for 416,088 shares.
21/01/22
CI
DHP Korea Co., Ltd. authorizes a Buyback Plan.
20/01/22
CI
Tranche Update on DHP Korea Co., Ltd.'s Equity Buyback Plan announced on March 23, 2020.
24/06/20
CI
Tranche Update on DHP Korea Co., Ltd.'s Equity Buyback Plan announced on March 23, 2020.
24/06/20
CI
DHP Korea Co., Ltd.'s Equity Buyback announced on March 23, 2020, has expired with 283,523 shares, representing 1.74% for KRW 2,015.98 million.
22/06/20
CI
DHP Korea Co., Ltd. announces an Equity Buyback for 373,134 shares.
23/03/20
CI
DHP Korea Co., Ltd. authorizes a Buyback Plan.
22/03/20
CI
DHP Korea Co., Ltd.(KOSDAQ:A131030) dropped from S&P Global BMI Index
23/09/19
CI
Allianz Global Investors Korea Limited acquired additional 1.75% stake in DHP Korea Co., Ltd..
08/01/17
CI
DHP Korea Co., Ltd.(KOSDAQ:A131030) added to S&P Global BMI Index
21/09/15
CI
Truston Asset Management Co., Ltd. and a related company acquired 5.25% in DHP Korea Co., Ltd..
22/06/15
CI
DHP Korea Ltd. completed the acquisition of HI Special Purpose Acquisition Company I from Eugene Asset Management Co., Ltd. and other shareholders in a reverse merger transaction.
14/11/13
CI
DHP Korea Ltd. entered into an agreement to acquire HI Special Purpose Acquisition Company I from Eugene Asset Management Co., Ltd. and other shareholders in a reverse merger transaction.
25/06/13
CI
Sam Chun Dang Pharm. Co.,Ltd completed the acquisition of 61.27% stake in DHP Korea Ltd.
27/12/12
CI
Sam Chun Dang Pharm. Co.,Ltd agreed to acquire 61.27% stake in DHP Korea Ltd. for approximately KRW 14 billion.
26/12/12
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Optus Pharmaceutical Co Ltd, formerly DHP Korea Co Ltd, is a Korea-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company is primarily engaged in the manufacture and sale of eye drops and ophthalmic preparations such as dry eye treatment agents, conjunctivitis treatment agents, anti-inflammatory medication agents, glaucoma treatment agents and others.
More about the company
1st Jan change
Capi.
+17.11% 72.29M +9.85% 72.5B +13.69% 9.11B -12.85% 5.07B +60.16% 5.01B +1.60% 3.85B -19.20% 2.46B +18.65% 2.44B +24.62% 2.27B -27.46% 2.26B
Specialty & Advanced Pharmaceuticals
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1